A. J. Kazimi

Insider Reports History

Location
Nashville, TN
Signature
A.J. Kazimi by /s/ John Hamm as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by A. J. Kazimi:

Form 4 holding Chairman and CEO, Director, 10%+ Owner

CUMBERLAND PHARMACEUTICALS INC

Security class
Options (right to buy)
Shares / value
568,000
Estimated value
$2,419,560
Report date
18 Mar 2026
Price
$5.17
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by A. J. Kazimi

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .